Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
Location: United States, Washington, Seattle
Employees: 1-10
Total raised: $25M
Investors 1
| Date | Name | Website |
| - | WRF Capita... | wrfseattle... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.08.2022 | Seed | $25M | - |
Mentions in press and media 4
| Date | Title | Description |
| 26.08.2026 | Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays | SEATTLE and RICHMOND, BC, Aug. 26, 2026 /PRNewswire/ -- Monod Bio, a Seattle-based AI-enabled protein design company, and SignalChem Biotech Inc., a wholly-owned subsidiary of Sino Biological, Inc. (SZSE: 301047), today announced a non-excl... |
| 17.08.2023 | The 30 young leaders who are forging a new future for the healthcare industry in 2023 | Your browser does not support the video element. This story is available exclusively to Insider subscribers. Become an Insider and start reading now. A new generation of leaders is transforming the healthcare industry. They're developing ne... |
| 16.08.2022 | Monod Bio Raises $25M in Seed Financing | Monod Bio, a Seattle, WA-based life sciences company developing custom diagnostic biosensors that emit light to detect specific biomolecules of interest, raised $25M in Seed funding. The round was led by Matrix Capital, with participation f... |
| 15.08.2022 | Biotech Startup Monod Bio Collects $25 Million Seed Financing | Startup Monod Bio Inc. has secured $25 million in seed financing to develop a new technology designed to speed disease detection and help physicians manage patients with chronic conditions. Seattle-based Monod is developing an instrument th... |